http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#Head http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#assertion http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#provenance http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#pubinfo http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#assertion http://purl.obolibrary.org/obo/DOID_9538 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9538 http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00262 http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association http://www.w3.org/2000/01/rdf-schema#label carmustine for injection usp is indicated as palliative therapy as a single agent or in established combination therapy in the following brain tumors glioblastoma brainstem glioma medulloblastoma astrocytoma ependymoma and metastatic brain tumors multiple myeloma in combination with prednisone relapsed or refractory hodgkin s lymphoma in combination with other approved drugs relapsed or refractory non hodgkin s lymphomas in combination with other approved drugs carmustine for injection usp is a nitrosourea indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following brain tumors glioblastoma brainstem glioma medulloblastoma astrocytoma ependymoma and metastatic brain tumors 1 multiple myeloma in combination with prednisone 1 relapsed or refractory hodgkin s lymphoma in combination with other approved drugs 1 relapsed or refractory non hodgkin s lymphomas in combination with other approved drugs 1 http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00262 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#provenance http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#pubinfo http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#sig http://purl.org/nanopub/x/hasSignature EIGJVkkOo/SD9boerfGX/Cw9T7Wxk2pgOfoANNcFprCPIUdptasUCD+cgHqzrRRy8hEI2qVhIAQn2FYq9xHu+uxAoAb9YocG6TIbmclu54d3yz6KIwKfeWzBvxwJWpAx7CO4jjyVbO8Vg7katHKdK215yyUMGiprV2k6V0OFyF4= http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 http://purl.org/dc/terms/created 2021-06-21T10:34:58.107+02:00 http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAcpHQB49gkJmnzG2jZyOLVZ7ccHneER04kMlZsUM8Ui4 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs